Cooperation of Sox4 with β-catenin/p300 complex in transcriptional regulation of the Slug gene during divergent sarcomatous differentiation in uterine carcinosarcoma
2016 · BMC Cancer · 37 citations
https://doi.org/10.1186/s12885-016-2090-y
M
Masashi Akiya
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
22
Papers
291
Citations
8
h-index
8
i10-index
Masashi Akiya is an academic researcher from The Cancer Institute Hospital. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Cancer Immunotherapy and Biomarkers & Cancer Cells and Metastasis. The author has an h-index of 8, co-authored 19 publications.
Papers by this author
worksTumor B7-H3 expression in diagnostic biopsy specimens and survival in patients with metastatic prostate cancer
2021 · Prostate Cancer and Prostatic Diseases · 21 citations
https://doi.org/10.1038/s41391-021-00331-6
Additional file 1: Figure S1. of Cooperation of Sox4 with β-catenin/p300 complex in transcriptional regulation of the Slug gene during divergent sarcomatous differentiation in uterine carcinosarcoma
2016 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.c.3600413_d1
Abstract PS4-01-12: Androgen receptor and FOXA1 in breast cancer: Prognostic insights from a treatment-naïve historical cohort
2026 · Clinical Cancer Research · 0 citations
https://doi.org/10.1158/1557-3265.sabcs25-ps4-01-12
Abstract PS5-07-07: Toward optimization of treatment strategies for early breast cancer: a multicenter observational study integrating whole genome and transcriptome sequencing within the National Whole Genome Project in Japan (WJOG16822B)
2026 · Clinical Cancer Research · 0 citations
https://doi.org/10.1158/1557-3265.sabcs25-ps5-07-07
Abstract PS4-10-16: Tumor Immune Microenvironment as a Predictive Marker of Neoadjuvant Pembrolizumab Combined with Chemotherapy (KEYNOTE-522 Regimen) Efficacy in Early Triple-Negative Breast Cancer
2026 · Clinical Cancer Research · 0 citations
https://doi.org/10.1158/1557-3265.sabcs25-ps4-10-16
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat